ANTIFUNGAL PROPHYLAXIS WITH POSACONAZOLE VS. FLUCONAZOLE OR ITRACONAZOLE IN PEDIATRIC PATIENTS WITH NEUTROPENIA

被引：0
|
作者：
Doering, M. [1 ]
Eikemeier, M. [1 ]
Schulz, A. [2 ]
Hartmann, U. [3 ]
Schwarze, C. P. [1 ]
Ebinger, M. [1 ]
Handgretinger, R. [1 ]
Mueller, I. [4 ]
机构：
[1] Univ Childrens Hosp Tubungen, Dept Pediat Hematol & Oncol, Tubingen, Germany
[2] Univ Childrens Hosp Ulm, Dept Pediat Hematol & Oncol, Ulm, Germany
[3] Univ Childrens Hosp Tubungen, Univ Pharm, Tubingen, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P570
引用
收藏
页码：S373 / S373
页数：1
相关论文
共 50 条
  • [21] Antifungal prophylaxis in transplant recipients - Itraconazole is superior to fluconazole.
    不详
    AMERICAN JOURNAL OF NURSING, 2003, 103 (09) : 64II - +
  • [22] Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation
    Sanchez-Ortega, I.
    Patino, B.
    Arnan, M.
    Peralta, T.
    Parody, R.
    Gudiol, C.
    Encuentra, M.
    Fernandez de Sevilla, A.
    Duarte, R. F.
    BONE MARROW TRANSPLANTATION, 2011, 46 (05) : 733 - 739
  • [23] Fluconazole vs. itraconazole in the treatment of tinea versicolor
    Montero-Gei, F
    Robles, ME
    Suchil, P
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (08) : 601 - 603
  • [24] Posaconazole vs fluconazole eficacy and safety of antifungal prophylaxis on patients with allogenic stem cell transplantation. Experience of a mexican center
    Milan-Salvatierra, Andrea I.
    Lizeth Acosta-Maldonado, Brenda
    Rivera-Fong, Liliana M.
    Pichardo-Cepin, Yayra M.
    Perez-Gomez, Karen D.
    Rodriguez-Pereira, Mauricio I.
    Acosta-Maldonado, Perla K.
    Valero-Saldana, Luis M.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 450 - 451
  • [25] Comparative analysis of fluconazole versus posaconazole as antifungal prophylaxis in allogeneic haematopoietic cell transplant patients
    Teo, C.
    Wong, Z.
    Poon, M. L. M.
    Tan, B.
    Tan, L. K.
    Lim, Z. Y.
    Lim, S.
    Koh, L. P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S323 - S323
  • [26] Primary antifungal prophylaxis with posaconazole vs fluconazole in early neutropenic phase after allogeneic stem cell transplantation
    Mele, A.
    Greco, G.
    De Risi, C.
    Sibilla, S.
    Rossini, B.
    Carlino, D.
    Citiso, S.
    Prete, E.
    Morciano, M. R.
    Peluso, A.
    Pavone, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S582 - S583
  • [27] Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience
    Takpradit, Chayamon
    Wangkittikal, Chonthida
    Rungmaitree, Supattra
    Buaboonnam, Jassada
    Narkbunnam, Nattee
    Phuakpet, Kamon
    Vathana, Nassawee
    Sanpakit, Kleebsabai
    Pongtanakul, Bunchoo
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 679 - 689
  • [28] Fluconazole v itraconazole prophylaxis in neutropenia following therapy for haematological malignancy.
    Prentice, AG
    Morgenstern, GR
    Prentice, HG
    Ropner, JE
    Schey, SA
    Warnock, DW
    BLOOD, 1997, 90 (10) : 1865 - 1865
  • [29] ANTIFUNGAL PROPHYLAXIS WITH ITRACONAZOLE IN PROLONGED NEUTROPENIA - CORRELATION WITH PLASMA-LEVELS
    BOOGAERTS, MA
    VERHOEF, GE
    ZACHEE, P
    DEMUYNCK, H
    VERBIST, L
    DEBEULE, K
    MYCOSES, 1989, 32 : 103 - 108
  • [30] COST-EFFECTIVENESS OF POSACONAZOLE VERSUS FLUCONAZOLE OR ITRACONAZOLE IN THE PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS AMONG NEUTROPENIC PATIENTS IN THAILAND
    Junjarunee, S.
    Numuang, K.
    Lerdlitruangsin, S.
    Itzler, R.
    VALUE IN HEALTH, 2014, 17 (07) : A806 - A806
12345